The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Open accessAbstract
Expression of HPV16 early region genes in basal keratinocytes of transgenic mice elicits a multistage pathway to squamous carcinoma. We report that infiltration by mast cells and activation of the matrix metalloproteinase MMP-9/gelatinase B coincides with the angiogenic switch in premalignant lesions. Mast cells infiltrate hyperplasias, dysplasias, and invasive fronts of carcinomas, but not the core of solid tumors, where they degranulate in close apposition to capillaries and epithelial basement membranes, releasing mast-cell-specific serine proteases MCP-4 (chymase) and MCP-6 (tryptase). MCP-6 is shown to be a mitogen for dermal fibroblasts that proliferate in the reactive stroma, whereas MCP-4 can activate progelatinase B and induce hyperplastic skin to become angiogenic in an in vitro bioassay. Notably, premalignant angiogenesis is abated in a mast-cell-deficient (KITW/KITWWv) HPV16 transgenic mouse. The data indicate that neoplastic progression in this model involves exploitation of an inflammatory response to tissue abnormality. Thus, regulation of angiogenesis during squamous carcinogenesis is biphasic: In hyperplasias, dysplasias, and invading cancer fronts, inflammatory mast cells are conscripted to reorganize stromal architecture and hyperactivate angiogenesis; within the cancer core, upregulation of angiogenesis factors in tumor cells apparently renders them self-sufficient at sustaining neovascularization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic and functional experiments indicate that neutrophils, mast cells, eosinophils and activated T lymphocytes also contribute to malignancies by releasing extracellular proteases, pro-angiogenic factors and chemokines11,23–26.”
From Inflammation and cancer (2002) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Self-citationWhat Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
RAG-1-deficient mice have no mature B and T lymphocytes
Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90030-g · Cited by 2,898
Proteins: Structures and Molecular Properties
Creighton, T. E. (1986) · Medical Entomology and Zoology · Cited by 2,645
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,737
Self-citationThe proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus
Chabot, B., Stephenson, D. A., Chapman, V. M., Besmer, P., & Bernstein, A. (1988) · Nature · doi:10.1038/335088a0 · Cited by 1,339
Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation
Kitamura, Y., Go, S.-R., & Hatanaka, K. (1978) · Blood · doi:10.1182/blood.v52.2.447.bloodjournal522447 · Cited by 830
Flagged first, then by citations
Research works printed but not linked: 3
- Caughey, G.H. 1995. Mast cell chymases and tryptases: Phylog- eny, family relations, and biogenesis. In Mast cell proteases in immunology and biology (ed. G.H. Caughey), pp. 305- 329.
- Folkman, J. and D. Hanahan. 1991. Expression of the angiogenic phenotype during development of murine and human can- cer. In Origins of human cancer: A comprehensive review (ed. J. Brugge, J. Curran, E. Harlow, and F. McCormick), pp. 803-814. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
- Westphal, E. 1891. Uber mastzellen. In Farbenanalytische Ut- ersuchuugen zur Histologie und Klinik des Blutes: gesam- melte Mitt(h)eilungen (ed. P. Ehrlich), Vol. 1, p. 17. Hirsch- wald Press, Berlin, Germany.
Cited by
Sorted by citations
Items 601–700 of 945
Activation of Mast Cells within a Tumor of Angiosarcoma: Ultrastructural Study of Five Cases
Demitsu, T., Inoue, T., Kakurai, M., Kiyosawa, T., Yoneda, K., & Manabe, M. (2002) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2002.tb00264.x · Cited by 16
Translation and Transcription: the Dual Functionality of LysRS in Mast Cells
Yannay-Cohen, N., & Razin, E. (2006) · Molecules and Cells · doi:10.1016/s1016-8478(23)17400-0 · Cited by 16
Brown, J. K., Hollenberg, M. D., & Jones, C. A. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00215.2005 · Cited by 16
“Related observations in a murine model of squamous epithelial carcinogenesis have suggested that tryptase participates in the induction of stromal architectural reorganization at the tumor margin, including inducing dermal fibroblast proliferation and activation of angiogenesis (28).”
BackgroundA Growth Factor Mixture That Significantly Enhances Angiogenesis in Vivo
Roethy, W., Fiehn, E., Suehiro, K., Gu, A., Yi, G., Shimizu, J., Wang, J., Zhang, G., Ranieri, J. P., Akella, R., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29255-7 · Cited by 16
“However, angiogenesis is not a process induced, sustained, or completed by a single molecule (Folkman and Klagsbrun, 1987; Beck and D’Amore, 1997; Coussens et al., 1999; Carmeliet, 2000; Carmeliet and Jain, 2000).”
Remodeling of Tumor Stroma and Response to Therapy
Johansson, A., & Ganß, R. (2012) · Cancers · doi:10.3390/cancers4020340 · Cited by 16
“Equally important are inflammatory cells, such as macrophages (also known as tumor associated macrophages, TAM), neutrophils and mast cells, which infiltrate solid tumors and create an immune suppressive environment which fosters tumor growth [4–6], affects clinical outcome [7,8] and/or therapeutic success [9].”
BackgroundNaito, H., Kidoya, H., Sato, Y., & Takakura, N. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp021 · Cited by 15
Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Heneberg, P. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798357881 · Cited by 15
Leukemic potential of doubly mutant Nf1 andWv hematopoietic cells
Ingram, D. A., Wenning, M. J., Shannon, K., & Clapp, D. W. (2003) · Blood · doi:10.1182/blood-2002-08-2635 · Cited by 15
Cinel, L., Aban, M., Bastürk, M., Ertunç, D., Arpacı, R. B., Dılek, S., & Ankaralı, H. Ç. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.10.011 · Cited by 15
Distinct Functions of Epidermal and Myeloid-Derived VEGF-A in Skin Tumorigenesis Mediated by HPV8
Ding, X., Lucas, T., Marcuzzi, G. P., Pfister, H., & Eming, S. A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3007 · Cited by 15
“Thus, our findings corroborate earlier studies reporting on vascular alterations during neoplastic progression in both human cervix carcinoma and the corresponding transgenic K14-HPV16 mouse model, speculating on a causal relationship of virus-induced carcinogenesis andneoangiogenesis (39, 40).”
BackgroundResultArena, G. O., Arena, V., Arena, M., & Abdouh, M. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.01.019 · Cited by 15
A Transcriptomic Insight into the Impact of Colon Cancer Cells on Mast Cells
Yu, Y., Blokhuis, B. R. J., Garssen, J., & Redegeld, F. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071689 · Cited by 15
“, MMP-9) and proteases (tryptase and chymase) degrade extracellular matrix (ECM) components and thereby favor the implantation of tumor cells [17,18].”
BackgroundRojas, I. G., Oreamuno, M. Y. V. B., Spencer, L., Flores, M., & Martínez, A. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01057.x · Cited by 14
Wensman, H., Kamgari, N., Alsing-Johansson, T., Grujić, M., Calounova, G., Lundequist, A., Rönnberg, E., & Pejler, G. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.01.009 · Cited by 14
“The antiodies used to detect 4-1BB were rabbit polyclonals against murine -1BB (TNFRSF9/CD 137, LS-C14232) and rabbit IgG control antiody (LS-C109221) (both from Lifespan biosciences, Seattle, WA). he Envision polymer system (Dako) together with DAB was used or detection.”
BackgroundCroci, D. O., Méndez‐Huergo, S. P., Cerliani, J. P., & Rabinovich, G. A. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_29 · Cited by 14
Carraway, R. E., & Cochrane, D. E. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.02.021 · Cited by 14
Targeting KIT on Innate Immune Cells to Enhance the Antitumor Activity of Checkpoint Inhibitors
Stahl, M. F., Gedrich, R. W., Peck, R., LaVallee, T. M., & Eder, J. P. (2016) · Immunotherapy · doi:10.2217/imt-2016-0040 · Cited by 14
Quail, D. F., & Joyce, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00019-6 · Cited by 14
Toh, B., Toh, B., Abastado, J., & Abastado, J. (2012) · OncoImmunology · doi:10.4161/onci.22196 · Cited by 15
Immune Cells and Inflammatory Mediators as Regulators of Tumor Angiogenesis
Palma, M. D., & Coussens, L. M. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_20 · Cited by 14
Self-citationColor-coded imaging of splenocyte-pancreatic cancer cell interactions in the tumor microenvironment
McElroy, M. K., Kaushal, S., Bouvet, M., & Hoffman, R. M. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6682 · Cited by 14
Lymphatic Vessels in Colorectal Cancer and Their Relation With Inflammatory Infiltrate
Sacchi, G., Weber, E., Aglianò, M., Lorenzoni, P., Rossi, A., Caruso, A. M., Vernillo, R., Gerli, R., & Lorenzi, M. (2003) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6494-4 · Cited by 14
Cancer vaccines: An unkept promise?
Kamath, V. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.006 · Cited by 13
Chu, Y., Wang, J., & Zhou, X. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.121 · Cited by 13
Tumour–host interactions: implications for developing anti-cancer therapies
Gadea, B. B., & Joyce, J. A. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406000172 · Cited by 13
A Bloody Conspiracy— Blood Vessels and Immune Cells in the Tumor Microenvironment
Terrassoux, L., Claux, H., Bacari, S., Meignan, S., & Furlan, A. (2022) · Cancers · doi:10.3390/cancers14194581 · Cited by 12
“Mast cells, for example, secrete VEGF-A, FGF2 (Fibroblast Growth Factor), CXCL8, and MMPs [28].”
BackgroundInfluentialNazari‐Khanamiri, F., Abdyazdani, N., Abbasi, R., Ahmadi, M., & Rezaie, J. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3874 · Cited by 12
“28 In situations that facilitate angiogenesis, certain (ECs) exhibit a sprouting response to angiogenic factors like VEGF ‐”
BackgroundBalamurugan, K., & Karthikeyan, J. (2012) · Biomedicine & Preventive Nutrition · doi:10.1016/j.bionut.2012.01.002 · Cited by 12
Shim, J. K., Kennedy, R. H., Weatherly, L. M., Abovian, A. V., Hashmi, H. N., Rajaei, A., & Gosse, J. A. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3738 · Cited by 12
FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions
Kim, M.-S., Kwon, Y., Jung, H. S., Kim, Y., & Jeoung, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194964 · Cited by 12
“Inflammatory mast cells can promote angiogenesis during squamous epithelial carcinogenesis via mast cell-specific proteases MCP-4 and MCP-6 [118].”
BackgroundThe Role of the Tumor Microenvironment in Regulating Angiogenesis
Watnick, R. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_1 · Cited by 12
The Role of Inflammatory Cells in Angiogenesis in Multiple Myeloma
Ribatti, D., & Vacca, A. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_14 · Cited by 12
Singaravel, V., Gopalakrishnan, A. S., Vijayakumar, R., & Raja, K. (2015) · Comparative Clinical Pathology · doi:10.1007/s00580-015-2203-z · Cited by 11
“Presence of increased cell numbers of inflammatory mast cells creates a tumour microenvironment that reflects a persistent inflammatory state, thereby promoting the development of tumour progression, angiogenesis and metastasis (Coussens et al. 1999; Tomita et al. 2000).”
BackgroundSpatial Distribution of Mast Cells Regulates Asymmetrical Angiogenesis at the Ocular Surface
Cho, W., Mittal, S. K., Elbasiony, E., & Chauhan, S. K. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.02.016 · Cited by 11
A Crucial Door to the Mast Cell Mystery Knocked In
Kawakami, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0990101 · Cited by 11
“The pathogenic roles of mast cells have been extended to include not only allergic diseases and helminth infection, but also autoimmune diseases such as experimental allergic encephalomyelitis (5) and rheumatoid arthritis (6), allograft tolerance (7), angiogenesis in tissue repair (8), and carcinogenesis (9).”
BackgroundMechanical Induction of an Epithelial Cell Chymase Associated with Wound Edge Migration
Firth, J. D., Uitto, V., & Putnins, E. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801975200 · Cited by 11
Mast Cells Influence the Proliferation Rate of Myeloma Plasma Cells
Pappa, C. A., Tsirakis, G., Stavroulaki, E., Kokonozaki, M., Xekalou, A., Konsolas, I., & Alexandrakis, M. G. (2015) · Cancer Investigation · doi:10.3109/07357907.2015.1008639 · Cited by 11
Choo, M., Kraft, S., Missero, C., & Park, J. M. (2018) · Science Signaling · doi:10.1126/scisignal.aau0727 · Cited by 11
The role of mast cells in human skin cancers
Ribatti, D., Tamma, R., Annese, T., & Enrico Crivellato, B. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00688-x · Cited by 11
Chapter 2 Managing Tumor Angiogenesis
Cuevas, I., & Boudreau, N. J. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)03002-4 · Cited by 12
“Vascular endothelial growth factor (VEGF), the most extensively characterized angiogenic factor, is produced and secreted by a number of normal cell types and its expression is markedly increased in tumor cells as well as in the immediate tumor stroma (Bergers et al., 2000; Chen et al., 2009; Coussens et al., 1999; Ke…”
BackgroundInfluentialThe Angiogenic Switch in Solid Tumors: Clinical Implications
Tosetti, F., Bertelli, R., & Albini, A. (2002) · Tumori Journal · doi:10.1177/03008916020016s103 · Cited by 11
Wu, H., Tao, A., Martin, J. D., Quader, S., Liu, X., Takahashi, K., Hespel, L., Miura, Y., Hayakawa, Y., Irimura, T., et al. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.03.031 · Cited by 11
Role of Hematopoietic Stem Cells in Angiogenesis
Suda, T., & Takakurab, N. (2001) · International Journal of Hematology · doi:10.1007/bf02982059 · Cited by 11
“Moreover, recent work showed that mast cells in the skin release chymase, which activates pro-MMP9 and is associated with stimulation of angiogenesis during squamous epithelial cell carcinogenesis [ 41 ].”
BackgroundRibatti, D. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1481609 · Cited by 10
Oral lichen sclerosus expressing extracellular matrix proteins and IgG4-positive plasma cells
Xavier, F. C. D. A., Prates, A. A., Gurgel, C. A. S., Souza, T. G. D. S. E., Andrade, R. G., Ramos, E. A. G., Ramalho, L. M. P., & dos Santos, J. N. (2014) · Dermatology Online Journal · doi:10.5070/d3209023910 · Cited by 10
Wałaszek, Z. (2010) · Oncology Letters · doi:10.3892/ol.2010.221 · Cited by 10
“Previous data indicate that mast cells and neutrophils potentiate the actions of HPV16 oncogenes (59,65) and amplify neoplastic cell proliferation and angiogenesis largely by the release of MMP-9.”
BackgroundPappa, C. A., Tsirakis, G., Devetzoglou, M., Zafeiri, M., Vyzoukaki, R., Androvitsanea, A., Xekalou, A., Sfiridaki, K., & Alexandrakis, M. G. (2014) · Tumor Biology · doi:10.1007/s13277-014-1747-x · Cited by 10
Farhadi, S., Shahsavari, F., & Davardan, M. (2016) · Pathology Research International · doi:10.1155/2016/8754567 · Cited by 10
“However, stimulatory role of mast cells in the growth of pathological lesions is more prevalent and obvious than their inhibitory effect [13].”
BackgroundIsabella, S., Mirunalini, S., & Kannaiyan, P. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0701-2 · Cited by 10
Rios, P. A. F. D. L., Soto‐Domínguez, A., Vertti, R. D. A. P., Castelán‐Maldonado, E. E., Gauna, S. E. V., Morán‐Martínez, J., Treviño, D. S., & García-Garza, R. (2020) · Acta Histochemica · doi:10.1016/j.acthis.2020.151618 · Cited by 10
Jaafari‐Ashkavandi, Z., Khademi, B., Akbari, S., & Malekzadeh, M. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.5.2955 · Cited by 10
“For the first time, in 1891, Westple described accumulation of mast cells around the tumors (Coussens et al., 1999).”
BackgroundHarmful effects of carbamazepine on the postnatal development of the rat ventral prostate
de Oliva, S. U., Scarano, W. R., Okada, F. K., & Miraglia, S. M. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-22 · Cited by 10
“Mast cells contribute to the development of skin cancer in K14-HPV16 transgenic mouse by proteases releasing, such as tryptase and chymase and stimulating angiogenesis [78].”
Proangiogenic cells enhanced persistent and physiologic neovascularization compared with macrophages
Choi, Y.-E., Cha, Y. R., Lee, K. M., Kim, H., & Yoon, C. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.60 · Cited by 10
Do cell-autonomous and non-cell-autonomous effects drive the structure of tumor ecosystems?
Tissot, T., Újvári, B., Solary, É., Lassus, P., Roche, B., & Frédéric Thomas, A. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.005 · Cited by 11
“involve the recruitment of stromal cells to promote angiogenesis [35, 36], of fibroblasts to generate a matrix [37,38], of innate immune cells”
BackgroundLiudahl, S. M., & Coussens, L. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809819-6.00008-3 · Cited by 14
Self-citationCarcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression
Strieth, S., Hartschuh, W., Pilz, L. R., & Fusenig, N. E. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600622 · Cited by 10
“Inflammatory cell infiltrates, as less specific angiogenesis inducers and frequently observed in epithelial skin neoplasms (Coussens et al, 1999), differed neither in distinct stages of skin carcinogenesis from actinic keratosis to SCCs (Strieth et al, 2000) nor in the KA subtypes, and are thus…”
BackgroundAngiogenesis and hematological malignancies
Lim, S. T., & Levine, A. M. (2005) · Hematology · doi:10.1080/10245330400018409 · Cited by 10
“[45–49].”
Polycationic peptides as inhibitors of mast cell serine proteases
Lundequist, A., Juliano, M. A., Juliano, L., & Pejler, G. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00044-3 · Cited by 10
Caughey, G. H. (2002) · Elsevier eBooks · doi:10.1016/b978-012079028-9/50084-3 · Cited by 10
Self-citationMast Cell Regulation of the Immune Response
Ryan, J. J., Morales, J. K., Falanga, Y. T., Fernando, J. F. A., & Macey, M. (2009) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3181c2a95e · Cited by 10
Stassi, A. F., Díaz, P. U., Gasser, F. B., Velázquez, M. M. L., Gareis, N. C., Salvetti, N. R., Ortega, H. H., & Baravalle, M. E. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.04.002 · Cited by 9
Do mast cells contribute to the continued survival of vertebrates?
Norrby, K. (2022) · Apmis · doi:10.1111/apm.13264 · Cited by 10
“As later reported, MCs secrete not only bFGF but VEGFA as well (51,52).”
BackgroundRibatti, D., & Crivellato, E. (2011) · Springer eBooks · doi:10.1007/978-94-007-1469-4_6 · Cited by 9
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis.
Hamid, K. M., & Mirshafiey, A. (2016) · PubMed · Cited by 9
Studies of Mast Cells: Adventures in Serendipity
Brown, M. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00520 · Cited by 9
“Among the perhaps unexpected activities of mast cells are roles in vascular disease (82), angiogenesis and tissue remodeling (83, 84), diabetic wound healing (85), migraine headaches (86), anxiety (87), metabolic syndromes (88), fertility (89, 90), and development of mammary glands (91).”
BackgroundAshem, H. N., Hamada, H. A., & Abbas, R. L. (2020) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2020.01.001 · Cited by 9
Jonsson, E. L., Nylander, K., HALLÉN, L., & Laurell, G. F. E. (2012) · Oncology Letters · doi:10.3892/ol.2012.907 · Cited by 9
“There is an established correlation between chronic inflammation and cancer (35) and mast cells are known to contribute to pre-malignant progression (36-39).”
Metaloproteinases: aspectos fisiopatológicos sistêmicos e sua importância na cicatrização
Araújo, R. V. D. S., Silva, F. O., de Melo-Júnior, M. R., & Porto, A. L. F. (2011) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v10i1.5470 · Cited by 9
Increased Mast Cell Counts in Benign and Malignant Salivary Gland Tumors
Jaafari‐Ashkavandi, Z., & Ashraf, M. J. (2014) · PubMed Central · doi:10.5681/joddd.2014.003 · Cited by 9
Mast Cells in Allergy and Tumor Disease
Wasiuk, A., de Vries, V. C., Nowak, E. C., & Noelle, R. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-451-7_6 · Cited by 9
“matrix metalloproteinase (MMP)-9 coincided with the angiogenic switch in early tumor lesions [92].”
BackgroundSquamous cell carcinoma and dental implants: A systematic review of case reports
Jeelani, S. A., Rajkumar, E., Mary, G., Khan, P., Gopal, H., Roy, S., Maheswaran, T., & Anand, B. (2015) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.163457 · Cited by 9
“[13] 14-20]”
Bone Marrow Angiogenesis in Systemic Mast Cell Disease
Baek, J.-Y., Li, C., Pardanani, A. D., Butterfield, J. H., & Tefferi, A. (2002) · Stem Cells and Development · doi:10.1089/152581602753448603 · Cited by 9
“Furthermore, both experimental and clinical data suggest that increased mast cell infiltration of tumor tissue may facilitate disease progression and may be associated with shortened patient survival (17,23,27,28).”
Human Mast Cell and Basophil/Eosinophil Progenitors
Gauvreau, G. M., & Denburg, J. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1568-2_4 · Cited by 9
Argininosuccinate synthase as a novel biomarker for inflammatory conditions
Cao, M., George, T. J., Prima, V., Nelson, D. R., & Svetlov, S. I. (2013) · Biomarkers · doi:10.3109/1354750x.2013.773080 · Cited by 8
“However, during later tumor growth, it appears proinflammatory factors, such as MMPs, come under direct control by the tumors themselves (Coussens et al., 1999).”
BackgroundInfluentialAdipocytes, mast cells and angiogenesis
Ribatti, D., Annese, T., & Tamma, R. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.4.07 · Cited by 9
“Mast cells infiltrate and MMP-9 activation coincided with the angiogenic switch in premalignant lesions, and premalignant angiogenesis was abrogated in a mast cell-deficient HPV16 transgenic mouse [68, 69].”
BackgroundThe tumor microenvironment as a target for anticancer treatment
Bizzarri, M., Cucina, A., & Proietti, S. (2014) · Oncobiology and Targets · doi:10.4103/2395-4469.145341 · Cited by 8
“[29] In turn, tissue fibrosis and modification of physical‐chemical properties of ECM may likely influence tumor onset and progression by regulating soluble factors involved in inflammation[30] and angiogenesis.[31]”
BackgroundSalvagno, C., & de Visser, K. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3801-8_10 · Cited by 8
Zhang, N., Schumacher, A., Fink, B., Bauer, M., Zenclussen, A. C., & Meyer, N. (2022) · Cells · doi:10.3390/cells11071158 · Cited by 8
“Another study indicated that chymase may induce angiogenesis by activating MMP9 to regulate ECM remodeling [86].”
BackgroundMast Cells and Tumor Microenvironment
Theoharides, T. C., Alysandratos, K., Angelidou, A., & Zhang, B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_17 · Cited by 8
“…of mast cells has been shown repeatedly with the use of W/W v mast cell deficient mice, which developed fewer lung metastases to subcutaneous B16-BL6 tumors (Starkey et al. 1988), and in which mice premalignant angiogenesis of squamous epithelial carcinogenesis was blocked (Coussens et al. 1999).”
BackgroundRegulation of colon gene expression by vitamin B 6 supplementation
Toya, K., Hirata, A., Ohata, T., Sanada, Y., Katô, N., & Yanaka, N. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100707 · Cited by 8
Impact of immunodeficiency on lingual carcinogenesis and lymph node metastasis in mice
Wang, S., Li, F., Dongxia, Q., Hu, Z., Meng, Y., Shi, L., Zhao, E., & Niu, Y. (2019) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12916 · Cited by 8
Bugge, T. H. (2003) · Elsevier eBooks · doi:10.1016/b978-012239990-9/50011-4 · Cited by 8
Braga, T., Ringvall, M., Tveit, H., Åbrink, M., & Pejler, G. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.10.019 · Cited by 8
Activated Akt-1 in specific cell populations during multi-stage skin carcinogenesis.
Affara, N. I., Schanbacher, B. L., Mihm, M. J., Cook, A. C., Pei, P., Mallery, S. R., Trempus, C. S., Bauer, J. A., & Robertson, F. M. (2004) · PubMed · Cited by 8
Mast cells and ocular surface: An update review
Barone, V., Scirocco, L., Surico, P. L., Micera, A., Cutrupi, F., Coassin, M., & Zazzo, A. D. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.109982 · Cited by 8
Gaje, P. N., Bocan, E. V., Cîmpean, A. M., Izvernariu, D. A., Streian, F., & Raica, M. (2007) · PubMed · Cited by 7
Germini, D. E., Franco, M. I. F., Fonseca, F. L. A., Gehrke, F. D. S., Alves, B. D. C. A., Cardili, L., Oshima, C. T. F., Theodoro, T. R., & Waisberg, J. (2019) · Tumor Biology · doi:10.1177/1010428319843042 · Cited by 7
Costa, A. C., Santos, J., Medeiros‐Fonseca, B., Oliveira, P. A., Bastos, M. M. S. M., Brito, H. O., da Costa, R. M. G., & Medeiros, R. (2022) · Cancers · doi:10.3390/cancers14092216 · Cited by 7
“In K14-HPV16 mice, it was shown that cutaneous mast cells release proteases and reorganize stromal architecture and hyperactivate angiogenesis [43].”
Backgroundvan de Nieuwenhof, H. P., Hebeda, K. M., Bulten, J., Otte‐Höller, I., Massuger, L. F. A. G., de Hullu, J. A., & van Kempen, L. C. L. T. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03635.x · Cited by 7
“fibroblast activation, extracellular matrix remodelling and activation of angiogenesis.(16,17) In order to find similarities and differences in the composition of the inflammatory response in vulvar premalignancy (LS and dVIN) and vulvar SCC that can support our hypothesis, we have quantified a subset of inflammatory…”
ResultEichten, A., Shen, H., & Coussens, L. M. (2005) · Current Protocols in Cytometry · doi:10.1002/0471142956.cy1205s32 · Cited by 7
Self-citationNakamura, T., Otsuka, S., Ichii, O., Sakata, Y., Nagasaki, K., Hashimoto, Y., & Kon, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077246 · Cited by 7
Alves, I. S. S., Coser, P. H. P., Loureiro, G. J. Z., da Gama, L. P. N., Ribeiro, F. D. S. S., Bautz, W. G., Coburn, K. L. A., Pacheco, M. D. S., & da Gama-de-Souza, L. N. (2016) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-016-9829-1 · Cited by 7
“, chymase and tryptase secretion by cells is an important aspect in tissue remodeling [25].”
BackgroundThe Development of Blood Vessels: Cellular and Molecular Mechanisms
Carmeliet, P. (2002) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-0109-0_1 · Cited by 7
Iba, Y., Shirai, M., Dei, C., Hirata, T., Harada, C., & Masukawa, T. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2006.12.012 · Cited by 7
Quiescent Hypervascularity Mediated by Gain of HIF-1 FunctionPreprint
Arbeit, J. M. (2002) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2002.67.133 · Cited by 7
The role of innate immune cells in modulating vascular dynamics in skin malignancies
Marciniak, M., Stachowicz-Suhs, M., & Wagner, M. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189331 · Cited by 6
Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer
Blümke, J., Schameitat, M., Verma, A., Limbecker, C., Arlt, E., Kessler, S. M., Kielstein, H., Krug, S., Bazwinsky‐Wutschke, I., & Hämmerle, M. (2025) · Cancers · doi:10.3390/cancers17101689 · Cited by 7
“Therefore, they contributed significantly to the angiogenic switch during tumor progression [150,151].”
TRIP13: A promising cancer immunotherapy target
Jing, S., Zhao, L., Zhao, L., Gao, Y., & He, T. (2024) · Cancer Innovation · doi:10.1002/cai2.147 · Cited by 6
“Mast cells, myeloid ‐ derived suppressor cells, and monocytes have been associated with an inflammatory microenvironment that promotes tumor growth [57, 74, 75].”
Session 2: Inflammation and Cancer
(2004) · Toxicologic Pathology · doi:10.1080/01926230490882402 · Cited by 6
Metadata
- Authors
- Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-06-01
- Volume
- 13
- Issue
- 11
- Pages
- 1382-1397
- ISSN
- 0890-9369 (ISSN-L)
- PMC
- PMC316772
- OpenAlex
- W2146440075
- Cited by
- 946
- References
- 87
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 11 · 2023: 13 · 2022: 27 · 2021: 18 · 2020: 29 · 2019: 31 · 2018: 27 · 2017: 29 · 2016: 39 · 2015: 32 · 2014: 52 · 2013: 32 · 2012: 49
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 24136, P01HL024136)
- National Cancer Institute (CA72006, P01CA072006)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- mast cells, angiogenesis, squamous cell carcinoma, HPV16, keratinocytes, MMP-9, chymase, tryptase, precancerous lesions, dermal fibroblasts, tumor stroma, inflammation, carcinogenesis, neovascularization
- MeSH terms
- Animals, Carcinoma, Squamous Cell, Extracellular Matrix, Humans, Mast Cells, Mice, Transgenic, Neovascularization, Pathologic, Serine Endopeptidases, Up-Regulation, Inflammation Mediators, Mice, Tryptases, Chymases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review